Scott B. Ullem - 16 Feb 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: CVP, Chief Financial Officer
Issuer ticker: EW
Reported as of: 16 Feb 2025
Net transaction value: -$13,257
SEC form: 4
Accepted by SEC: 18 Feb 2025, 18:18:44 UTC
Prior SEC filing: 13 Feb 2025
Next SEC filing: 28 Feb 2025
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Scott B. Ullem filed Form 4 for Edwards Lifesciences Corp (EW) on 18 Feb 2025.

Key facts

This page summarizes Scott B. Ullem's Form 4 filing for Edwards Lifesciences Corp (EW).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Feb 2025, 18:18.

Change

Previous filing in this sequence was filed on 13 Feb 2025.
Current net transaction value: -$13,257.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Tax liability

Transaction value: $13,257
Shares: -174
Change %: -0.57%
Price: $76.19
Shares after: 30,387
Date: 16 Feb 2025
Ownership: Direct

EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 266,318
Date: 16 Feb 2025
Ownership: By Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.